Explore the full record of transactions filed by Black Jeffrey G., Chief Financial Officer. Director active across 3 companies, notably EXAGEN INC.. Aggregated, 8 disclosures have been logged. Total volume traded: €800k. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Jeffrey G. Black is the Chief Financial Officer of Exagen Inc. and Apollo Endosurgery, Inc. He is responsible for the financial management of these companies, including budget planning and financial performance analysis. His role is essential in ensuring the profitability and growth of these organizations. Jeffrey works closely with other executives to align financial and strategic objectives.